Merck Recalls Three Lots of Invanz Due to Glass Shards

Voluntary recall of batches sparked by broken glass

FRIDAY, July 6 (HealthDay News) -- Three lots of Invanz (ertapenem sodium) were recalled this week due to two incidents in which pieces of broken glass were found in the reconstituted solution for injection. Merck & Co., Inc., of Whitehouse Station, N.J., issued a letter to health care professionals noting that it is working closely with the U.S. Food and Drug Administration to inform its direct customers of the recall.

Invanz contains 1 g of the broad spectrum antibiotic ertapenem sodium and is used to treat a wide range of infections including diabetic foot infections, intra-abdominal infections, skin and skin structure infections, community-acquired pneumonia, acute pelvic infections and complicated urinary tract infections. The lot numbers concerned are 0803930, 0803940, 0803950 and all three have an October 2008 expiry date.

"In addition, if you are a direct customer of Merck & Co., Inc. and have further distributed these lots of Invanz, please contact all accounts to the hospital level to ensure affected product is returned," the letter states.

The company believes that the number of vials that may contain glass particles is "extremely low" and "in the event that a dose of Invanz was administered and did contain glass particles, the risk of associated medical harm is unlikely."

More Information

Physician's Briefing